Pittenger & Anderson Inc. lessened its position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 86.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 409 shares of the medical instruments supplier's stock after selling 2,547 shares during the quarter. Pittenger & Anderson Inc.'s holdings in West Pharmaceutical Services were worth $123,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in WST. Fidelis Capital Partners LLC bought a new position in West Pharmaceutical Services in the 1st quarter valued at $27,000. Crewe Advisors LLC lifted its holdings in West Pharmaceutical Services by 322.7% during the 2nd quarter. Crewe Advisors LLC now owns 93 shares of the medical instruments supplier's stock valued at $31,000 after buying an additional 71 shares in the last quarter. Northwest Investment Counselors LLC purchased a new stake in West Pharmaceutical Services in the 3rd quarter valued at about $30,000. ORG Partners LLC grew its stake in West Pharmaceutical Services by 820.0% in the 1st quarter. ORG Partners LLC now owns 138 shares of the medical instruments supplier's stock worth $55,000 after acquiring an additional 123 shares in the last quarter. Finally, Quest Partners LLC raised its stake in shares of West Pharmaceutical Services by 5,633.3% during the second quarter. Quest Partners LLC now owns 172 shares of the medical instruments supplier's stock valued at $57,000 after acquiring an additional 169 shares in the last quarter. 93.90% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at West Pharmaceutical Services
In other West Pharmaceutical Services news, VP Charles Witherspoon sold 703 shares of the stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $310.40, for a total transaction of $218,211.20. Following the completion of the sale, the vice president now directly owns 1,253 shares of the company's stock, valued at approximately $388,931.20. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.53% of the stock is owned by corporate insiders.
West Pharmaceutical Services Stock Up 1.8 %
NYSE:WST traded up $5.91 during mid-day trading on Wednesday, reaching $329.38. The company's stock had a trading volume of 616,080 shares, compared to its average volume of 570,392. The company has a quick ratio of 2.23, a current ratio of 3.00 and a debt-to-equity ratio of 0.07. West Pharmaceutical Services, Inc. has a 1 year low of $265.00 and a 1 year high of $413.70. The stock has a fifty day moving average of $302.32 and a 200-day moving average of $318.15. The firm has a market capitalization of $23.85 billion, a PE ratio of 47.99, a price-to-earnings-growth ratio of 23.71 and a beta of 1.00.
West Pharmaceutical Services (NYSE:WST - Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.50 by $0.35. The company had revenue of $746.90 million for the quarter, compared to analyst estimates of $709.62 million. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. West Pharmaceutical Services's revenue was down .1% compared to the same quarter last year. During the same period last year, the company posted $2.16 earnings per share. Equities research analysts forecast that West Pharmaceutical Services, Inc. will post 6.69 earnings per share for the current year.
West Pharmaceutical Services Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 20th. Investors of record on Wednesday, November 13th will be paid a dividend of $0.21 per share. This is a boost from West Pharmaceutical Services's previous quarterly dividend of $0.20. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date is Wednesday, November 13th. West Pharmaceutical Services's dividend payout ratio is 11.87%.
West Pharmaceutical Services Profile
(
Free Report)
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Featured Stories
Before you consider West Pharmaceutical Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and West Pharmaceutical Services wasn't on the list.
While West Pharmaceutical Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
